ABPI sets out new proposals to support the NHS and economic growth

ABPI

1 March 2023 - The pharmaceutical industry’s offer includes an annual £1 billion boost to the NHS as well as an additional £1billion new investment facility to maximise the potential of the UK’s health and life science ecosystem.

Among the proposals is a fixed rebate rate of 6.88% levied across all eligible NHS medicine sales to be paid by the industry.

Read ABPI press release 

Michael Wonder

Posted by:

Michael Wonder